JMP Securities Downgrades Globus Medical (GMED) to Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/19/2024
- Stocks end near flat as investors assess earnings, data
- Netflix Q1 earnings top estimates on blowout subscriber growth
- Taiwan Semi (TSM) Q1 profit beats expectations on AI demand
- Stocks have priced in much of the 2024 optimism - Wells Fargo
- Intuitive Surgiical (ISRG) beats earnings, revenue expectations in Q1
- Tritium DCFC Limited (DCFC): Three Australian subsidiaries were determined to be insolvent or likely to become insolvent
- Hasbro (HAS) Announces Resignation of Cynthia Williams, President of Wizards of the Coast and Hasbro Gaming
- Frontier Communications (FYBR) says third party had gained unauthorized access to portions of its information technology environment
- Ibotta (IBTA) Prices 6.56M Share IPO at $88/sh
- Netflix (NFLX) Tops Q1 EPS by 77c, Offers Guidance
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
- Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
- After-hours movers: Alcoa rises; Equifax and Las Vegas Sands fall
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
- After-hours movers: United Airlines, J.B. Hunt, and more
William Blair Downgrades Globus Medical (GMED) to Market Perform
November 9, 2016 7:30 AM ESTWilliam Blair downgraded Globus Medical (NYSE: GMED) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Globus Medical click here. For more ratings news on Globus Medical click here.
Shares of Globus Medical closed at $22.33 yesterday.
... MoreOppenheimer Downgrades Globus Medical (GMED) to Perform
November 9, 2016 7:29 AM ESTOppenheimer downgraded Globus Medical (NYSE: GMED) from Outperform to Perform with a price target of $23.00 (from $29.00).
For an analyst ratings summary and ratings history on Globus Medical click here. For more ratings news on Globus Medical click here.
Shares of Globus Medical closed at $22.33 yesterday.
... MoreGlobus Medical (GMED) Reports In-Line Q3 EPS
November 8, 2016 4:22 PM ESTGlobus Medical (NYSE: GMED) reported Q3 EPS of $0.29, in-line with the analyst estimate of $0.29. Revenue for the quarter came in at $135.7 million versus the consensus estimate of $139.25 million.
GUIDANCE:
Globus Medical sees FY2016 EPS of $1.20, versus the consensus of $1.20. Globus... More
